Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.
about
Heterodimerization of alpha 2A- and beta 1-adrenergic receptorsDopamine D4 receptor oligomerization--contribution to receptor biogenesisCoexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosisDopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin AHeteromeric association creates a P2Y-like adenosine receptorHeteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.Receptor heteromerization and drug discovery.Acromegaly pathogenesis and treatmentThe active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid raftsPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsHypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2Dimerization and phosphorylation of thyrotropin-releasing hormone receptors are modulated by agonist stimulationOligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activationThe role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout miceLipid membrane reorganization induced by chemical recognition.Heteromerization of ciliary G protein-coupled receptors in the mouse brainSchizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerizationLow affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptorsFunctional characterization of G-protein-coupled receptors: a bioinformatics approach.Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout miceFunctional expression of heteromeric calcitonin gene-related peptide and adrenomedullin receptors in yeast.Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes.A novel approach for the identification of protein-protein interaction with integral membrane proteins.Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrateGonadotropin-releasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transfer.Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).Research Resource: Real-Time Analysis of Somatostatin and Dopamine Receptor Signaling in Pituitary Cells Using a Fluorescence-Based Membrane Potential Assay.Management of acromegaly in Latin America: expert panel recommendationsSeven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.Positive regulation by GABA(B)R1 subunit of leptin expression through gene transactivation in adipocytes.Chaperoning G protein-coupled receptors: from cell biology to therapeuticsMutant G protein alpha subunit activated by Gbeta gamma: a model for receptor activation?Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration.Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells.Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic miceSleep-deprivation induces changes in GABA(B) and mGlu receptor expression and has consequences for synaptic long-term depression.Role of antibodies in developing drugs that target G-protein-coupled receptor dimers.Antipsychotic-induced gene regulation in multiple brain regions.
P2860
Q24292697-C511D631-41F5-49DB-AA05-943B349BF0DFQ24293127-CE211D65-CD86-4F40-9D32-26917BEEB180Q24337066-D920F92B-2EAC-45B1-B4D6-EC5AC8358481Q24604923-A233DBE3-2998-435C-93CA-E87524BA62B6Q24629017-A8806E28-5C1A-4119-B971-C4DDC67E1D2EQ24630645-E71A4F00-80FA-45B2-8833-6FE619D2AB98Q24631740-D259F284-5AF6-476D-AEE9-B75858FC003AQ24647360-D1AF2A1E-39D8-4369-A62B-F12517B16D6DQ24675155-AB7A4F01-A37B-432F-B10A-3BC7222639FCQ26862544-ADB73EEA-4414-4B5F-9F93-10A1EF1924C4Q28190374-FCA70C21-FBE0-4EB3-B6A3-D8C36C79BBD5Q28209959-EE22EFF5-4EB4-4884-BEF1-AE721687717BQ28218765-68CE40CD-E815-4103-BE51-FC2CEEB42FC2Q28345401-44171393-118C-4361-8E20-BC8D1C51ED93Q28348761-59F0307E-F0BA-4D9D-AE21-38272FB71694Q28361988-F2AAC1DB-5C76-4E22-8BC0-72C872913C8EQ28508883-99BABDCC-61CA-4DEE-865B-0969B7F171AEQ28567232-3CA34DBB-05CE-4BAD-9B6C-783685ED49BDQ28585319-09C935B0-BD26-4A68-9333-B5FB0EF48251Q30009384-8118F465-03C9-40E0-A469-2AE4B4B6A38BQ30412976-631D3773-D6EC-45BA-949B-2542CA00CD6AQ30717334-3A2C04A7-C226-417D-9770-D30941B01AC2Q30857101-3E419516-449F-42B0-8130-33B11ADE4355Q30885049-018D8E73-31D5-4FB2-A18B-1572E80B40EFQ30978584-E325BCB1-086B-46A7-AB37-A1D8874230CEQ30997054-9E2E8EFF-EAFC-4E70-93C0-5116C43CE9F9Q31466586-76886308-B54F-437D-849F-B2AC46CEB265Q31777917-10DD6929-33AC-4F60-9062-7AD2B6250C7FQ33631389-5D27325F-811C-46D4-9488-25511D091F7BQ33794388-5ACE1B91-2C8C-4FEC-B609-25A94D7B0DCFQ33890786-F1086710-ED60-4693-AD88-7476DC1F607DQ33927260-8DC16B25-FB36-4E3F-9D5C-520A8D1ED316Q33927508-5F166742-EB1E-49E2-B855-E99CC788CED7Q33946075-17298EAC-AD1C-4C13-9C4E-BACDE8C7155BQ33983589-4AD346D3-6122-4840-A3D9-5EF6A3285E14Q34017536-E591B1E4-C45E-47D3-BE4B-2A003C714E93Q34017941-A453C1E0-173A-4AAE-B445-1F6A4CFECC43Q34042882-860E76EE-1C6D-409B-890F-0741A6925A02Q34051430-CD3B1897-2DAA-4215-BB96-FAB4DC597CB1Q34066954-A6C73C85-58A4-4B12-8AC6-612EBE69B102
P2860
Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Receptors for dopamine and som ...... enhanced functional activity.
@ast
Receptors for dopamine and som ...... enhanced functional activity.
@en
type
label
Receptors for dopamine and som ...... enhanced functional activity.
@ast
Receptors for dopamine and som ...... enhanced functional activity.
@en
prefLabel
Receptors for dopamine and som ...... enhanced functional activity.
@ast
Receptors for dopamine and som ...... enhanced functional activity.
@en
P2093
P1433
P1476
Receptors for dopamine and som ...... enhanced functional activity.
@en
P2093
P304
P356
10.1126/SCIENCE.288.5463.154
P407
P577
2000-04-01T00:00:00Z